Thrombolysis Not Necessary in Mild Nondisabling Stroke: ARAM

Dual antiplatelet treatment was noninferior to thrombolysis with regard to functional outcome at 90 days for Chinese patients with minor nondisabling stroke.

Related Keywords

Cherry Hill , New Jersey , United States , Texas , Boston , Massachusetts , China , University Of Cincinnati , Ohio , Dallas , Chinese , American , Tudor Jovin , Pooja Khatri , Thanh Nguyen , National Institutes Of Health Stroke Scale , International Stroke Conference , Boston Medical Center , Cooper Neurological Institute , American Heart Association Stroke , Among Chinese , Medscape Cardiology , National Institutes , Health Stroke Scale , American Heart , American Stroke Association , Modified Rankin Scale , Antiplatelet Therapy Now Standard , Stroke , Erebrovascular Accident , Va Cerebrovascular Accident , Cerebrovascular Disease , Thrombolytic Therapy , Thromboembolism , Ischemic Stroke , Aspirin , Intravenous Iv , Intravenous , Tv , Clinical Guidelines , Guidelines , Tissue Plasminogen Activator Tpa , Pa Tissue Plasminogen Activator , Intracranial Hemorrhage , Intracranial Bleeding , Heart , Hemorrhage , Bleeding , Hospitals , Recurrent Str ,